Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors

NCT02934256 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Li Peng

Collaborators